Over the last decade, opioid use has quadrupled in pregnant persons, with overdose becoming a leading cause of pregnancy-related death. As the opioid crisis impacts this demographic, there is urgency within the medical community to expand expertise and treatment...
Currently, under Massachusetts law, healthcare providers are mandated to report a person to the Department of Children & Families (DCF) for suspected abuse or neglect when they give birth to a baby who was exposed to substances designated as “addictive...
Researchers from Boston Medical Center’s Maxwell Finland Laboratory for Infectious Diseases have identified properties in placenta tissue that may play an important role in preventing the transmission of COVID-19 from a mother with the virus to her fetus. The study...
THE BOTTOM LINE | Implementation of Eat, Sleep, Console, a new family-centered care model, improved outcomes for both infants with neonatal opioid withdrawal syndrome (NOWS) and moms with opioid use disorder — all without any adverse...
Naltrexone, buprenorphine, and methadone are the three medications that are FDA-approved to treat opioid use disorder (OUD). However, for pregnant women recovering from opioid use, only methadone and buprenorphine, both opioid agonists, are currently recommended. The...